Hedge fund profile
Sofinnova Bioequities Master Fund, Ltd.
Sofinnova Bioequities Master Fund, Ltd. is reported as a hedge fund in Form ADV private-fund disclosures. The adviser is Sofinnova Investments, Inc., based in Menlo Park, California, United States.
$121.4Mgross assets
$3.0Mminimum
50owners
3(c)(7)exemption
Disclosure fields
Fund facts
SEC private fund ID805-6556194744
Reference ID183470
JurisdictionCayman Islands
Fund of fundsNo
Master fundYes
Feeder fundNo
Non-US ownership0%
Assets valued100%
Annual auditYes
GAAPYes
Source periodMarch 2026
Date submitted03/27/2026 02:07:52 PM
Adviser
TypeRegistered investment adviser
SEC number801-110134
CRD160297
Regulatory AUM$5.4B
Compliance signals
Exempt from registration Sales limitation not marked Prime brokers reported Custodians reported
Service providers
Reported counterparties
General partners
Sofinnova Bioequities Gp LLC
Auditors
KPMG, LLP
Prime brokers
JEFFERIES LLCJ.P. MORGAN SECURITIES INC.GOLDMAN SACHS & CO. LLC
Custodians
GOLDMAN SACHS INTERNATIONALJEFFERIES LLCGOLDMAN SACHS & CO. LLCBNY MELLON TRUST COMPANY (IRELAND) LIMITEDCITCO BANK CANADAJ.P. MORGAN SECURITIES LLC
Administrators
CITCO FUND ADMINISTRATION (CAYMAN ISLANDS) LIMITED
Same adviser